C-PAP/PHEN/PROST/Atrop 150/7 — Class II drug recall D-1547-2016
Terminated recall by Pharmacy Plus, Inc. dba Vital Care Compounder, reported 2016-10-05, distributed in MS. Lack of Assurance of Sterility
| Recall number | D-1547-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pharmacy Plus, Inc. dba Vital Care Compounder, Hattiesburg, MS, United States |
| Recall initiated | 2016-07-26 |
| Classified | 2016-09-27 |
| Reported by FDA | 2016-10-05 |
| Terminated | 2016-11-18 |
| Distributed | MS |
| Quantity | 1 vials |
| Reason classes | sterility |
| Lot numbers | 397877 |
| Expiration dates | 2017-01-06 |
Product
C-PAP/PHEN/PROST/Atrop 150/7.5 (Papaverine 150mg/Phentolamine 7.5mg/Prostaglandin 75mcg/Atropine 1mg injection), 10 ml vial containing 5.9ml solution, Rx, Vital Care Compounder, Hattiesburg, MS
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1547-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.